Table 2.
Variable | Univariate analysis P | Multivariate anlaysis | Selected factors for building model | ||||
---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | ||
Age, years | < 0.001 | < 0.001 | < 0.001 | ||||
≥ 70 | Reference | Reference | |||||
< 70 | 1.733 | 1.536–1.956 | < 0.001 | 1.745 | 1.547–1.968 | < 0.001 | |
Tumor histology | < 0.001 | < 0.001 | < 0.001 | ||||
Papillary histology | Reference | Reference | |||||
Adenocarcinoma and others histology | 1.667 | 1.236–2.248 | < 0.001 | 1.684 | 1.251–2.266 | < 0.001 | |
Squamous histology | 2.111 | 1.410–3.161 | < 0.001 | 2.282 | 1.536–3.390 | < 0.001 | |
Tumor grade | < 0.001 | 0.469 | |||||
I | Reference | ||||||
II | 0.997 | 0.814–1.221 | 0.975 | ||||
III | 1.103 | 0.895–1.360 | 0.358 | ||||
IV | 1.103 | 0.759–1.603 | 0.607 | ||||
Tumor size, cm | < 0.001 | 0.156 | |||||
< 3 | Reference | ||||||
3–5 | 1.116 | 0.968–1.287 | 0.131 | ||||
5–10 | 1.133 | 0.965–1.331 | 0.127 | ||||
≥ 10 | 1.343 | 0.989–1.825 | 0.059 | ||||
Pathologic T category | < 0.001 | < 0.001 | < 0.001 | ||||
T1 | Reference | Reference | |||||
T2 | 0.994 | 0.783–1.263 | 0.963 | 1.003 | 0.790–1.273 | 0.982 | |
T3 | 1.960 | 1.530–2.510 | < 0.001 | 2.064 | 1.619–2.632 | < 0.001 | |
T4 | 2.244 | 1.570–3.206 | < 0.001 | 2.384 | 1.682–3.381 | < 0.001 | |
Pathologic N category | < 0.001 | < 0.001 | < 0.001 | ||||
N0 | Reference | Reference | |||||
N1 | 2.024 | 1.770–2.316 | < 0.001 | 2.076 | 1.818–2.370 | ||
N2 | 2.026 | 1.557–2.637 | < 0.001 | 2.086 | 1.606–2.709 | ||
Pathologic M category | < 0.001 | < 0.001 | < 0.001 | ||||
M0 | Reference | Reference | |||||
M1 | 2.242 | 1.915–2.626 | < 0.001 | 2.300 | 1.969–2.687 | < 0.001 | |
Sex | 0.083 | ||||||
Male | |||||||
Female | |||||||
Resection type | 0.062 | ||||||
Radical resection | |||||||
Palliative resection | |||||||
Tumor number | < 0.001* | ||||||
Single tumor | |||||||
Multiple tumors |
*The tumor number was excluded in the multivariable analysis, since its hazard ratio was less than 1, which was contrary to the factor that patients with more tumors had worse survival outcome